National Financial Statements From 2010 to 2024

WX6 Stock   73.50  1.50  2.08%   
National Health financial statements provide useful quarterly and yearly information to potential National Health Investors investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on National Health financial statements helps investors assess National Health's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting National Health's valuation are summarized below:
National Health Investors does not presently have any fundamental ratios for analysis.
Check National Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among National Health's main balance sheet or income statement drivers, such as , as well as many indicators such as . National financial statements analysis is a perfect complement when working with National Health Valuation or Volatility modules.
  
This module can also supplement various National Health Technical models . Check out the analysis of National Health Correlation against competitors.

National Health Investors Company Net Income Analysis

National Health's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

More About Net Income | All Equity Analysis

Current National Health Net Income

    
  66.4 M  
Most of National Health's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, National Health Investors is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition
Based on the recorded statements, National Health Investors reported net income of 66.4 M. This is much higher than that of the sector and significantly higher than that of the Net Income industry. The net income for all Germany stocks is notably lower than that of the firm.

National Health Investors Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining National Health's current stock value. Our valuation model uses many indicators to compare National Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across National Health competition to find correlations between indicators driving National Health's intrinsic value. More Info.
National Health Investors is rated below average in current valuation category among its peers. It also is rated below average in price to book category among its peers . The ratio of Current Valuation to Price To Book for National Health Investors is about  1,825,784,077 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the National Health's earnings, one of the primary drivers of an investment's value.

About National Health Financial Statements

National Health shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although National Health investors may analyze each financial statement separately, they are all interrelated. The changes in National Health's assets and liabilities, for example, are also reflected in the revenues and expenses on on National Health's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for National Stock Analysis

When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.